GAMOGEN INC
10QSB, EX-27.1, 2000-12-20
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: GAMOGEN INC, 10QSB, 2000-12-20
Next: GABELLI FUNDS INC ET AL, SC 13D/A, 2000-12-20



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                        3-MOS
<FISCAL-YEAR-END>                          FEB-28-2000
<PERIOD-END>                               NOV-30-2000
<CASH>                                           6,456
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 6,456
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 192,469
<CURRENT-LIABILITIES>                            1,579
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        13,750
<OTHER-SE>                                     177,140
<TOTAL-LIABILITY-AND-EQUITY>                   192,469
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,622
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    361
<INCOME-TAX>                                       520
<INCOME-CONTINUING>                              (159)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (159)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0








</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission